^
    Apply
    A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer (MAGNITUDE) (NCT03748641)
    Phase 3
    Janssen Research & Development, LLC
    Active, not recruiting
    Last update posted :
    02/20/2025
    Initiation :
    01/25/2019
    Primary completion :
    10/08/2021
    Completion :
    03/19/2027
    HRD • BRCA
    |
    Zejula (niraparib) • abiraterone acetate • prednisone • Akeega (abiraterone/niraparib)
    CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations (NCT05689021)
    Phase 2
    Mayo Clinic
    Recruiting
    Last update posted :
    05/13/2024
    Initiation :
    03/05/2024
    Primary completion :
    09/01/2024
    Completion :
    09/01/2025
    SPOP
    |
    SPOP mutation
    |
    Zejula (niraparib) • abiraterone acetate • Akeega (abiraterone/niraparib)